| abstract |
A vaccine for eliciting immunity against Schistosoma nparasites, comprises a recombinant fusion protein capablenof comprising the 27/28 kDa cercarial elastase sequence ofn S. mansoni or an active fragment, homologue or variantnthereof, fused to a suitable bacterial, phage or viralnprotein, together with a pharmaceutically acceptablenexcipient or carrier. The vaccine can be used to combat S.nmansoni, S. japonicum and/or S. haematobium in mammals,nespecially humans. |